Free Trial

Veru (VERU) Competitors

Veru logo
$0.53 +0.00 (+0.91%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VERU vs. NUS, NATR, MED, EL, PBH, IPAR, HLF, USNA, STOK, and ORIC

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Stoke Therapeutics (STOK), and ORIC Pharmaceuticals (ORIC).

Veru vs.

Veru (NASDAQ:VERU) and Nu Skin Enterprises (NYSE:NUS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings.

Veru currently has a consensus target price of $4.33, suggesting a potential upside of 717.61%. Nu Skin Enterprises has a consensus target price of $6.88, suggesting a potential upside of 23.10%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nu Skin Enterprises
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

47.2% of Veru shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 14.9% of Veru shares are held by insiders. Comparatively, 1.7% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Veru has a beta of -0.69, meaning that its stock price is 169% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Nu Skin Enterprises has a net margin of -8.46% compared to Veru's net margin of -223.85%. Nu Skin Enterprises' return on equity of 5.86% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Veru-223.85% -112.75% -67.54%
Nu Skin Enterprises -8.46%5.86%2.62%

In the previous week, Nu Skin Enterprises had 3 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nu Skin Enterprises and 1 mentions for Veru. Nu Skin Enterprises' average media sentiment score of 1.25 beat Veru's score of 0.94 indicating that Nu Skin Enterprises is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nu Skin Enterprises
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veru has higher earnings, but lower revenue than Nu Skin Enterprises. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M4.59-$37.80M-$0.26-2.04
Nu Skin Enterprises$1.73B0.16-$146.59M-$2.95-1.89

Nu Skin Enterprises received 240 more outperform votes than Veru when rated by MarketBeat users. However, 69.82% of users gave Veru an outperform vote while only 63.81% of users gave Nu Skin Enterprises an outperform vote.

CompanyUnderperformOutperform
VeruOutperform Votes
273
69.82%
Underperform Votes
118
30.18%
Nu Skin EnterprisesOutperform Votes
513
63.81%
Underperform Votes
291
36.19%

Summary

Nu Skin Enterprises beats Veru on 10 of the 18 factors compared between the two stocks.

Remove Ads
Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$77.44M$6.48B$5.29B$7.37B
Dividend YieldN/A3.24%5.11%4.31%
P/E Ratio-2.036.8321.7017.78
Price / Sales4.59228.36378.1494.74
Price / CashN/A65.6738.1534.64
Price / Book2.945.876.423.98
Net Income-$37.80M$142.26M$3.20B$247.33M
7 Day Performance1.05%7.58%4.73%4.31%
1 Month Performance6.85%-14.16%-9.88%-7.80%
1 Year Performance-54.31%-9.81%10.77%1.40%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
1.9572 of 5 stars
$0.53
+0.9%
$4.33
+717.6%
-58.2%$77.44M$16.89M-2.03230News Coverage
NUS
Nu Skin Enterprises
3.6921 of 5 stars
$6.22
-3.4%
$6.88
+10.5%
-54.1%$309.33M$1.73B-2.113,700Gap Down
NATR
Nature's Sunshine Products
3.5292 of 5 stars
$11.47
-2.6%
$19.00
+65.6%
-37.2%$212.01M$454.36M13.03850Analyst Upgrade
Short Interest ↓
News Coverage
Gap Down
MED
Medifast
3.8213 of 5 stars
$13.01
-1.4%
$16.50
+26.9%
-62.3%$142.25M$602.46M72.25870Positive News
EL
Estée Lauder Companies
4.7547 of 5 stars
$52.98
+0.1%
$86.00
+62.3%
-61.5%$19.02B$15.18B-27.1763,000Analyst Forecast
PBH
Prestige Consumer Healthcare
4.1553 of 5 stars
$81.41
-1.7%
$93.33
+14.6%
+17.4%$4.03B$1.12B19.07540News Coverage
Positive News
High Trading Volume
IPAR
Inter Parfums
3.9444 of 5 stars
$103.21
-0.9%
$162.80
+57.7%
-18.1%$3.32B$1.45B22.15530Short Interest ↑
Positive News
HLF
Herbalife
4.3378 of 5 stars
$7.78
-6.0%
$12.00
+54.3%
-23.5%$788.03M$4.99B3.1210,100Positive News
USNA
USANA Health Sciences
4.7869 of 5 stars
$24.69
-3.1%
$36.00
+45.8%
-45.5%$466.84M$854.50M8.731,900Upcoming Earnings
STOK
Stoke Therapeutics
3.2597 of 5 stars
$6.01
+1.1%
$24.67
+310.8%
-39.3%$324.74M$36.56M-2.86100Analyst Revision
ORIC
ORIC Pharmaceuticals
3.479 of 5 stars
$4.55
-6.8%
$18.86
+314.4%
-50.4%$323.17MN/A-2.5080
Remove Ads

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners